Edurne García Vidal
Edurne García Vidal obtained a degree in Biochemistry from the Autonomous University of Barcelona (UAB) in 2013. She continued her studies at the University of Barcelona (UB), where she completed an MSc in Genetics and Genomics in 2014, developing her post-graduate project at the Centre for Genomic Regulation (CRG) in Barcelona and undertaking her practical sessions in the clinical laboratory of the Dr. Josep Trueta University Hospital (Girona). In 2015 she worked at the ISOPlexis Germplasm Bank in Portugal and commenced doctoral studies at IrsiCaixa in 2016.
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection.
ADAR1 function affects HPV replication and is associated to recurrent human papillomavirus-induced dysplasia in HIV coinfected individuals.